Mobile

A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treat...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000679-32

A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomised, open, parallel-group, multicentre, 26 weeks study

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to compare the efficacy of Symbicort Single Inhaler Therapy with conventional best standard treatment in patients with persistent asthma.

Critère d'inclusion

  • This is a Phase IIIB trial to be conducted in patients with persistent asthma

Liens